SCHEMBL7490079

SCHEMBL7490079

CCOC(=O)COc1cccc2c1CCC(O)C2N1CCCC1c1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 11/20 0.64
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTGDR Q13258 3/20 0.34
NR4A2 P43354 2/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
F2RL3 Q96RI0 1/20 0.33
GABRA5 P31644 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498945 0.91 PTGIR (0.74) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7500464 0.91 PTGIR (0.69) PTGIRPTGDR
SCHEMBL7485719 0.90 PTGIR (0.79) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7485254 0.90 PTGIR (0.79) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7483521 0.90 PTGIR (0.79) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7490127 0.90 PTGIR (0.79) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7490049 0.90 PTGIR (0.79) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7493823 0.89 PTGIR (0.71) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7494834 0.87 PTGIR (0.75) PTGIRKMT2AALDH1A1MAPTKDM4E
SCHEMBL7494915 0.87 PTGIR (0.74) PTGIRKMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed